Evidence map›Paper›PMID 29321518›Full record

ArticleJournal of human genetics2018

Mediation analysis of alcohol consumption, DNA methylation, and epithelial ovarian cancer.

Dongyan Wu, Haitao Yang, Stacey J Winham, Yanina Natanzon, Devin C Koestler, Tiane Luo, Brooke L Fridley, Ellen L Goode, Yanbo Zhang, Yuehua Cui

Open access · greenAbstract read
In one paragraph

Article in Journal of human genetics, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
1.7field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 26 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Article
  5. Article
  6. A Review of High-Dimensional Mediation Analyses in DNA Methylation Studies.Methods in molecular biology (Clifton, N.J.) · 2022
    Review
  7. Article
  8. Review
  9. Article
  10. Gene-based mediation analysis in epigenetic studies.Briefings in bioinformatics · 2021
    Article
  11. Review
  12. Review
  13. Review
  14. Article
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 5 institutions in 2 countries.

Dongyan WuDivision of Health Statistics, School of Public Health, Shanxi Medical University, Taiyuan, Shanxi, 030001, China.
Haitao YangDivision of Health Statistics, School of Public Health, Hebei Medical University, Shijiazhuang, 050017, China.
Stacey J WinhamDepartment of Health Sciences Research, College of Medicine, Mayo Clinic, Rochester, MN, 55905, USA.
Yanina NatanzonDepartment of Health Sciences Research, College of Medicine, Mayo Clinic, Rochester, MN, 55905, USA.
Devin C KoestlerDepartment of Biostatistics, The University of Kansas Medical center, Kansas City, KS, 66160, USA.
Tiane LuoDivision of Health Statistics, School of Public Health, Shanxi Medical University, Taiyuan, Shanxi, 030001, China.
Brooke L FridleyDepartment of Biostatistics and Bioinformatics, Moffitt Cancer Center, Tampa, FL, 33612, USA.ORCID http://orcid.org/0000-0001-7739-7956
Ellen L GoodeDepartment of Health Sciences Research, College of Medicine, Mayo Clinic, Rochester, MN, 55905, USA.
Yanbo ZhangDivision of Health Statistics, School of Public Health, Shanxi Medical University, Taiyuan, Shanxi, 030001, China.
Yuehua CuiDivision of Health Statistics, School of Public Health, Shanxi Medical University, Taiyuan, Shanxi, 030001, China. cui@stt.msu.edu.
Shanxi Medical University · CNMayo Clinic · USHebei Medical University · CNMoffitt Cancer Center · USUniversity of Kansas Medical Center · US

Funding

Women's Cancer ProgramP30CA015083 · NCI · MAYO CLINIC ROCHESTER · PI AKHILESH PANDEY · 1985 to 2026
$151.3M
Use of microfluidic tumor cultures to enable clinical trials of therapies for ovarian cancerP50CA136393 · NCI · MAYO CLINIC ROCHESTER · PI ELLEN L. GOODE · 2009 to 2026
$37.0M
Mayo Cancer Genetic Epidemiology Training ProgramR25CA092049 · NCI · MAYO CLINIC ROCHESTER · PI PETERSEN, GLORIA M., VACHON, CELINE M · 2001 to 2018
$5.3M
Genetic Variation in the NF-kappaB Pathway and Ovarian Cancer EtiologyR01CA122443 · NCI · MAYO CLINIC ROCHESTER · PI GOODE, ELLEN L. · 2007 to 2012
$2.7M
NCI NIH HHS P30 CA015083NCI NIH HHS P50 CA136393NCI NIH HHS R01 CA122443NCI NIH HHS R25 CA092049
6 · The paper itself

Abstract

Epigenetic factors and consumption of alcohol, which suppresses DNA methylation, may influence the development and progression of epithelial ovarian cancer (EOC). However, there is a lack of understanding whether these factors interact to affect the EOC risk. In this study, we aimed to gain insight into this relationship by identifying leukocyte-derived DNA methylation markers acting as potential mediators of alcohol-associated EOC. We implemented a causal inference test (CIT) and the VanderWeele and Vansteelandt multiple mediator model to examine CpG sites that mediate the association between alcohol consumption and EOC risk. We modified one step of the CIT by adopting a high-dimensional inference procedure. The data were based on 196 cases and 202 age-matched controls from the Mayo Clinic Ovarian Cancer Case-Control Study. Implementation of the CIT test revealed two CpG sites (cg09358725, cg11016563), which represent potential mediators of the relationship between alcohol consumption and EOC case-control status. Implementation of the VanderWeele and Vansteelandt multiple mediator model further revealed that these two CpGs were the key mediators. Decreased methylation at both CpGs was more common in cases who drank alcohol at the time of enrollment vs. those who did not. cg11016563 resides in TRPC6 which has been previously shown to be overexpressed in EOC. These findings suggest two CpGs may serve as novel biomarkers for EOC susceptibility.

Indexed as

Alcohol DrinkingDisease SusceptibilityDNA MethylationModels, StatisticalAdultAgedAged, 80 and overAlgorithmsCarcinoma, Ovarian EpithelialCase-Control StudiesCpG IslandsEpigenesis, GeneticFemaleHumansLeukocytesMiddle Aged

Identifiers

PMID29321518
PMCPMC5985822
OpenAlexW2782738838

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.